Somerset Indus Capital Partners makes investment in Natural Capsules’ arm

22 Jun 2023 Evaluate

Somerset Indus Capital Partners has invested around Rs 75 crore at a pre-money valuation of Rs 250 crore in Natural Capsules’ unlisted subsidiary -- Natural BioGenex (NBPL). As a result of this transaction, Somerset will hold a stake of between 23% and 28% in NBPL, underscoring their confidence in the company's growth potential and long-term success. 

NBPL is constructing a state-of-the-art Greenfield facility in Tumkur, near Bengaluru. This state-of-the-art plant will manufacture active pharmaceutical ingredients (APIs), including Betamethasone, Dexamethasone, and Prednisolone, along with their intermediates and derivatives. The facility will not only enhance India's self-reliance in the API manufacturing sector but also contribute to the reduction of import dependency, particularly from China.

Natural Capsules is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Natural Capsules Share Price

175.20 -2.55 (-1.43%)
18-Dec-2025 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.20
Dr. Reddys Lab 1278.20
Cipla 1504.15
Zydus Lifesciences 915.50
Lupin 2120.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×